A Study of LY3561774 in Participants With Mixed Dyslipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

March 4, 2024

Study Completion Date

May 23, 2024

Conditions
DyslipidemiasLipid Metabolism DisordersMetabolic DiseasesHyperlipoproteinemia
Interventions
DRUG

LY3561774

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (41)

2600

Sanatorio San Martin, Venado Tuerto

5016

Clínica Privada Velez Sarsfield, Córdoba

10029

Icahn School of Medicine at Mount Sinai, New York

15401

Preferred Primary Care Physicians, Uniontown

20745

MD Medical Research, Oxon Hill

31217

Investigacion En Salud Y Metabolismo Sc, Chihuahua City

33343

Mersin University, Mersin

34096

Istanbul University Cerrahpasa Medical School Internal Diseases Institute, Istanbul

35100

Ege Universitesi Hastanesi, Bornova

41380

Kocaeli Üniversitesi, Kocaeli

42080

Necmettin Erbakan Meram Medical Fac., Meram

44670

Virgen Cardiovascular Research SC, Guadalajara

64060

Cardiolink Clin Trials, Monterrey

66465

Unidad Médica para la Salud Integral, San Nicolás de los Garza

97070

Medical Care and Research SA de CV, Mérida

06708

Chase Medical Research, LLC, Waterbury

02721

NECCR PrimaCare Research, Fall River

08611

Premier Research, Trenton

C1027AAP

Centro de Investigaciones Metabólicas (CINME), Ciudad Autónoma de Buenos Aire

C1430CKE

Glenny Corp, Buenos Aires

C1061AAS

CIPREC, CABA

C11056ABF

Investigaciones Medicas Imoba Srl, Buenos Aires

C1425AGC

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, Ciudad Autonoma de Buenos Aire

C1426ABP

Fundación Respirar, Buenos Aires

X5002HWE

Centro de Investigaciones Clinicas Instituto del Corazon (CICIC), Córdoba

S3000FWO

Centro de Investigaciones Clinicas del Litoral, Santa Fe

V1Y 1Z9

OCT Research ULC, Kelowna

M6B 3H7

North York Diagnostic and Cardiac Centre, North York

G7H 7K9

Ecogene-21, Chicoutimi

J4V 2G8

Viacar Recherche Clinique, Greenfield Park

G1V 4W2

Clinique des Maladies Lipidiques de Québec, Québec

565-0853

Medical Corporation Heishinkai OCROM Clinic, Suita-shi

103-0028

Medical Corporation Chiseikai Tokyo Center Clinic, Chuo-ku

160-0008

Heishinkai Medical Group ToCROM Clinic, Shinjuku-ku

530-0001

AMC Nishiumeda Clinic, Osaka

85-231

NZOZ Centrum Medyczne KERmed, Bydgoszcz

32-615

"Niepubliczny Zakład Opieki Zdrowotnej Przychodnia z Sercem", Grojec

33-122

Centrum Zdrowia Tuchów, Wierzchosławice

02-097

Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie, Warsaw

80-546

Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk

07070

Akdeniz Universitesi Hastanesi, Antalya

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY